Many openings around the country...but does anyone know when the next training session is and where? Also, can someone give more information on the ADHD medicine. When is it expected to be approved etc. Serious answers only.
If for CNS you're referring to Aptiom, you will not get to sell the new ADHD med. If you're referring to Latuda, their is a gap in the timeline between the loss of Latuda's patent and the launch of dasotriline.
I am referring to the adhd med with sunovion. Gap meaning LOE with Latuda and then a space for the FDA to approve dasotraline? If Latuda goes generic in 2018, dasotraline should be out.
There are no guarantees in Pharmaceutical R&D but the word is that dasotraline will be filed next year and approved in 2018. There are other things that must be worked through with the DEA concerning this drug class I believe but the plan has dasotraline launching before the Latuda LOE which is early 2019. I just joined this company 7 months ago and I have found it to be a very positive environment and I have not noticed that many people leaving. Good luck
Haven't seen anyone leave? You fool, most people here are new to the company and are happy to just have a job. Almost all the good ones have left for greener pastures.
